Fox News Novartis AIN457 demonstrates efficacy in psoriasis treatment Pharmaceutical business concern Review Novartis has according positive data from iii Phase II trials which tested the efficacy of AIN457 (secukinumab) to delicacy moderate-to-severe plaque psoriasis . AIN457 is a full human, targeted monoclonal antibody that specifically binds to and ... Novartis' disease of the skin Drug AIN457 Shows affirmative Results In 3 state of matter II Trials RTT tidings Study: Drug Helps With Psoriasis Symptoms Fox tidings Novartis Phase II collection show AIN457 provided rapid and significant relief of ... Reuters (press release) PMLiVE all 24 tidings articles » Link To Article
No comments:
Post a Comment